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RIG-I is a critical RNA virus sensor that serves to
initiate antiviral innate immunity. However, post-
translational regulation of RIG-I signaling remains
to be fully understood. We report here that RNA
viruses, but not DNA viruses or bacteria, specifically
upregulate lectin family member Siglecg expres-
sion in macrophages by RIG-I- or NF-kB-dependent
mechanisms. Siglec-G-induced recruitment of SHP2
and the E3 ubiquitin ligase c-Cbl to RIG-I leads to
RIG-I degradation via K48-linked ubiquitination at
Lys813 by c-Cbl. By increasing type I interferon
production, targeted inactivation of Siglecg protects
mice against lethal RNA virus infection. Taken to-
gether, our data reveal a negative feedback loop of
RIG-I signaling and identify a Siglec-G-mediated
immune evasion pathway exploited by RNA viruses
with implication in antiviral applications. These find-
ings also provide insights into the functions and
crosstalk of Siglec-G, a known adaptive response
regulator, in innate immunity.
INTRODUCTION
Innate immunity is the first line of host defense against virus
infection. Pattern recognition receptors (PRRs), including Toll-
like receptors (TLRs) and RIG-I-like receptors (RLRs), are main
sensors of the invading viruses (Kawai and Akira, 2010; Barbalat
et al., 2011; Rehwinkel and Reis e Sousa, 2010). TLR3, 7, 8, and 9
detect viral RNAs and DNAs in the endosome, whereas RLR
members RIG-I and MDA5 sense viral RNAs in the cytoplasm
(Kato et al., 2011). Upon recognizing invading viruses, PRRs acti-
vate downstream signaling pathways to initiate innate immune
response through the induction of type I interferons (IFNs).
TLRs-mediated signaling pathways recruit adaptor proteins
such as MyD88 and TIR-domain-containing adaptor-inducingIFN-b (TRIF), leading to the activation of transcription factors
that regulate the expression of proinflammatory cytokines and
type I IFNs (Kawai and Akira, 2011). RIG-I and MDA5 both
contain DExD/H box RNA helicase with two caspase-recruiting
domain (CARD)-like sequences and a helicase domain (Yo-
neyama et al., 2004; 2005). RIG-I, the most important member
of RLHs, recognizes cytoplasmic viral RNA such as that of
hepatitis V virus and influenza virus and induces IFN-b produc-
tion (Kowalinski et al., 2011; Seth et al., 2005; Hou et al., 2011;
O’Neill and Bowie, 2011). Insufficient IFN production causes
chronic infection, whereas excessive IFN causes autoimmune
and/or inflammatory diseases. Thus, precise control of RIG-I
signaling is critical for efficient viral clearance without harmful
immunopathology.
The different kinds of PRRs can cross-regulate their down-
stream signaling events in either a synergistic or antagonistic
manner (Kawai and Akira, 2011). Extensive interplays between
PRRs and other pivotal immune mediators and receptors also
orchestrate the outcome of host innate immune defenses. For
example, the activation of RLR resulted in the selective suppres-
sion of transcription of the gene encoding the p40 subunit of
interleukin 12 that was effectively induced by the activation of
TLRs. Cross-interference of RLR and TLR signaling pathways
modulates antibacterial T cell responses (Negishi et al., 2012).
The distinct classes of PRRs overlap in the spectrum of path-
ogen-associated molecular patterns (PAMPs) that they recog-
nized and cross-integrate their downstream signal pathways;
PRRs signaling is also cross-modulated by signaling generated
via other membrane-associated receptors. For example, innate
immunity utilizes members of the host lectin family (i.e., C-type
lectin receptors, sialic-acid-binding immunoglobulin-like lectins
[Siglecs], and galectins) as PRRs to detect viruses or transduce
signals (van Kooyk and Rabinovich, 2008; Vasta, 2009). How-
ever, the role of lectins in innate immune response and their
crosstalk with the RIG-I pathway in antiviral innate response
have not been established.
Our systemic analyses identified several genes of lectin family
that were upregulated significantly in macrophages in response
to infection with RNA viruses. Among them, we focused onCell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc. 467
Siglec-G, as it was upregulated the most and the quickest upon
RNA virus infection. Moreover, our experiments indicated that
knocking down Siglecg with siRNA in macrophages increased
the VSV-induced IFN-b mRNA expression most potently com-
pared with knocking down other lectin genes. These preliminary
results indicated the importance of Siglec-G in antiviral innate
immunity. In addition, the mouse homolog of human Siglec-10
had been independently identified by us and others (Li et al.,
2001; Munday et al., 2001; Whitney et al., 2001), and the func-
tional study of Siglec-G attracted our attention. Siglec-G belongs
to the family of Siglecs, which has intracellular domains with ITIM
(Pillai et al., 2012), known as inhibitory receptor of B1 cells (Hoff-
mann et al., 2007; Ding et al., 2007). Recent studies demonstrate
that the CD24-Siglec-G/10 interaction is important for the nega-
tive regulation of host response to danger-associated molecular
patterns (DAMPs) (Chen et al., 2009, 2011). However, the biolog-
ical functions of Siglec-G and its role in antiviral innate immunity
remained elusive.
Ubiquitination is one of the most versatile posttranslational
modifications and is also indispensable for antiviral infection.
Posttranslational modification of RIG-I and downstream sig-
naling proteins by different types of ubiquitination has been
found to be a key event in the regulation of RIG-I-triggered
NF-kB and IRF3 activation (Loo and Gale, 2011). K63-linked
ubiquitination by TRIM25 (Gack et al., 2007), or RING finger
protein leading to RIG-I activation (Riplet/REUL/RNF135) (Osh-
iumi et al., 2009) and free K63-linked polyubiquitin chains
(Zeng et al., 2010) have been shown to induce RIG-I activation.
On the other hand, RIG-I also undergoes ubiquitination by
RNF125 for proteasomal degradation (Arimoto et al., 2007).
However, which and how ubiquitin ligases and ubiquitin binding
scaffold proteins contribute to regulation of RIG-I signaling
remains to be illuminated.
Here, we report that RNA virus infection upregulates Siglecg
expression via the NF-kB pathway. Mice with targeted mutation
of Siglecg are protected against vesicular stomatitis virus (VSV)
infection with much more type I IFN production. Siglec-G asso-
ciates with c-Cbl and RIG-I via SHP2, promoting RIG-I protea-
somal degradation after conjugation to K48-linked ubiquitin by
c-Cbl. Our data demonstrate a negative feedback regulation of
RIG-I-mediated antiviral innate immune response through post-
translational modification of RIG-I.
RESULTS
RNA Viral Infection Specifically Upregulates Siglecg
Expression in Macrophages via NF-kB-Dependent
Mechanism
In order to identify molecules selectively involved in the regula-
tion of innate response against RNA viral infection, we analyzed
gene expression profiles in mouse peritoneal macrophages in-
fected with the RNA virus VSV. Focusing on the expression of
lectin family genes, we found that VSV infection significantly
changed the mRNA level of several lectins, including C-type
lectin receptors and Siglecs (Figure 1A). Upregulation of the
expression of a panel of lectin family genes was further validated
by quantitative PCR (Q-PCR) in macrophages infected with
various pathogens, including VSV, DNA virus (herpes simplex468 Cell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc.virus I [HSV-1]), intracellular bacteria (Listeria monocytogenes
[LM]), or extracellular Gram-negative bacteria (Escherichia coli
[E. coli]). Among these genes, the mRNA level of Siglec-G was
upregulated most significantly and quickly from 4 to 12 hr after
infection with VSV, but not by infection with HSV-1, LM, or
E. coli (Figure 1B). siRNA knockdown of Siglecg in macrophages
increased the VSV-induced IFN-b mRNA expression most
potently compared with knocking down other lectin genes
(Figure S1A available online). Upregulation of Siglecg expres-
sion was VSV (MOI) dose dependent (Figure S1B). Further,
Siglecg was upregulated in macrophages transfected with
poly(I:C) or infected with another RNA virus, the Sendai virus
(SeV), but remained unchanged in macrophages stimulated
with various TLR ligands or transfected with LM genomic DNA,
poly(dA:dT), or poly(dG:dC) (Figures 1C, S1C, and S1D). These
data suggest that the infection of RNA viruses, but not DNA
viruses or bacteria, specifically upregulates Siglecg expression
in macrophages.
We further assessed VSV infection-induced Siglecg expres-
sion in peritoneal macrophages derived from Rigi/, Irf3/,
Ifnb/, or IfnabR/mice and wild-type (WT) mice-derived peri-
toneal macrophages pretreated with PDTC, a NF-kB inhibitor,
PD98059 (MEK inhibitor), SP600125 (JNK inhibitor), SB203580
(P38 inhibitor), Wortmannin (PI3K inhibitor), or Go¨ 6976 (PKC
inhibitor). VSV-infection-induced upregulation ofSiglecg expres-
sionwasattenuated inRigi/macrophagesorWTmacrophages
pretreated with PDTC (Figures 1D, 1E, and S1E). VSV-infection-
induced upregulation of Siglecg expression was unaffected in
Irf3/, Ifnb/, or IfnabR/ mice-derived macrophages as
compared to WT mice-derived macrophages (Figure S1F).
Consistent with a role for NF-kB, Siglecg promoter-luc activity
increased in HEK293T cells ectopically overexpressing the p65
subunit of NF-kB with or without RNA virus (SeV) infection (Fig-
ure S1G). The data suggest that RNA viral infection upregulates
Siglecg expression via RIG-I-triggered NF-kB signaling.
Histone modifications play important roles in the control of
gene transcription. By ChIP assay, we found that H3K4me3
was upregulated and H3K27me3 was downregulated in the
promoter of Siglecg gene in macrophages after VSV infection,
whereas both H3K4me3 and H3K27me3 remained constant
throughout the stimulation with LPS (Figure 1F). It has been re-
ported that histonemethyltransferaseMLLmediatesmethylation
of H3K4 (Wang et al., 2009), and another chromatin H3K4 meth-
yltransferase, SET7/9, is an important coactivator of NF-kB (Li
et al., 2008). Chromatin immunoprecipitation (ChIP) experiments
showed that VSV infection, but not LPS stimulation, could
increase both SET7/9 and MLL enrichment at Siglecg promoter
in macrophages (Figures 1G and 1H). Taken together, our find-
ings demonstrate that RNA viral infection specifically upregu-
lates Siglecg expression in macrophages via an NF-kB-depen-
dent mechanism and may also involve epigenetic modification
of histone H3.
Siglecg Deficiency Protects Mice from Infection with
RNA Viruses
To investigate the role and functional significance of Siglec-G
in host antiviral innate response, we challenged Siglecg/
mice with RNA viruses VSV and SeV. VSV titer and replication
Figure 1. RNA Viral Infection Upregulates
Siglecg Expression by Histone H3 Modifi-
cation through the NF-kB Pathway
(A) Microarray analysis of mouse peritoneal
macrophages infected with VSV. Shown is the
heatmap of lectin family genes upregulated or
downregulated in macrophages following VSV
infection for 8 hr. Untreated macrophages were as
control.
(B) Q-PCR analysis of Siglec-G, Klre1, Clec2l,
Clec2j, and Colec11 mRNA expression in macro-
phages infected with LM, E. coli, HSV-1, or VSV for
the indicated hours. Data were normalized to the
expression of b-actin reference gene.
(C) Q-PCR analysis of Siglec-G mRNA expres-
sion in macrophages transfected with poly(I:C)
(intracellular poly(I:C)), stimulated with poly(I:C), or
infected with RNA virus SeV for the indicated
hours.
(D) Q-PCR analysis of Siglec-G mRNA expression
in Rigi/ macrophages infected with VSV.
(E) Q-PCR analysis of Siglec-G mRNA expression
in macrophages pretreated for 1 hr with NF-kB
inhibitor PDTC (10 mM) before VSV infection for
indicated hours.
(F) ChIP analysis of macrophages treated for
4 hr with LPS or VSV by using H3K4me3 and
H3K27me3 antibodies. Two sets of primers and
probes (P1 and P2) of Siglec-G used for Q-PCR.
(G and H) ChIP analysis of macrophages treated
for indicated hourswith LPS or VSV by using SET7/
9 antibody (G) or MLL antibody (H).
Data are means ± SEM. *p < 0.05; **p < 0.01. See
also Figure S1.in organs from Siglecg/ mice were significantly reduced
compared to Siglecg+/+ mice (Figures 2A and 2B). Siglecg/
mice were also more resistant to VSV infection in overall survival
assays (Figure 2C). Less infiltration of inflammatory cells was
observed in the lungs of Siglecg/ mice after infection with
VSV (Figure 2D) or SeV (Figure S2A). Immunohistochemical
staining for the macrophage glycoprotein F4/80 and neutro-
phil’s azurophilic granules myeloperoxidase (MPO) demon-
strated that less macrophages and neutrophils infiltrated in
the lung from Siglecg/ mice than from Siglecg+/+ mice in-
fected with VSV (Figure S2B). Similar infiltration of inflammatory
cells was detected in the lungs from Siglecg/ and Siglecg+/+
mice infected with DNA virus HSV-1 (Figure S2A). Consistent
with increased resistance, Siglecg/ mice produced higher
levels of IFN-b than Siglecg+/+ mice in response to infectionCell 152, 467–478with VSV (Figure 2E) or SeV (Figure S2C).
In contrast, TNF-a and IL-6 production
was unaffected by Siglecg deletion. We
also noted higher IFN-b mRNA expres-
sion in the organs and peritoneal macro-
phages of Siglecg/ mice than in those
of Siglecg+/+ mice infected with VSV
(Figures 2F and 2G) or SeV (Figures
S2D and S2E). Upregulation of IFN-b is
also specific to RNA virus infection, asno significant difference in IFN-b production or mRNA expres-
sion was observed in mice infected with HSV-1 (Figures S2C–
S2E). To further characterize the dynamics of chronic VSV
infection, we measured VSV loads in lung homogenate super-
natants and observed the pathological changes of lung from
Siglecg/ and Siglecg+/+ mice infected with lower-dose VSV.
As detected by TCID50 assay, VSV loads in organ samples
from Siglecg/ mice were significantly lower than in organs
from Siglecg+/+ mice on days 1 and 3, and VSV loads declined
below the limitation of detection on day 5 and remained unde-
tectable through day 14 postinfection (Figure S2F). Inflamma-
tory changes observed in lungs were consistent with viral loads
(Figure S2G). These data demonstrate that Siglecg/ mice
develop more potent innate response against RNA viral infec-
tion by producing more IFN-b., January 31, 2013 ª2013 Elsevier Inc. 469
Figure 2. Siglecg-Deficient Mice Are More
Resistant to RNA Viral Infection by Pro-
ducing More IFN-b
(A) Determination of VSV loads in organs by TCID50
assay 24 hr after Siglecg+/+ and Siglecg–/– mice
(n = 6 per group) were intraperitoneally injected
with VSV.
(B) Q-PCR analysis of VSV expression in organs
from Siglecg+/+ and Siglecg–/– mice in (A).
(C) Survival of 7-week-old Siglecg+/+ and Si-
glecg–/– mice given intraperitoneal injection of VSV
(1 3 108 pfu/g) (n = 10 per group). p < 0.01.
(D) Pathology of Siglecg+/+ and Siglecg–/– mice
in response to VSV. Scale bar, 100 mm. Hema-
toxylin and eosin staining of lung sections from
mice in (A).
(E) ELISA of cytokine production in sera from Si-
glecg+/+ and Siglecg–/– mice in (A).
(F) Q-PCR analysis of IFN-b mRNA expression in
organs from Siglecg+/+ and Siglecg–/– mice in (A).
(G) Q-PCR analysis of IFN-b mRNA expression
in peritoneal macrophages from Siglecg+/+ or Si-
glecg–/– mice in (A).
Data are means ± SEM. **p < 0.01. See also
Figure S2.Siglec-G Selectively Inhibits RNA-Virus-Induced Type I
Interferon Production in Macrophages and Dendritic
Cells
Upon infection with VSV or SeV, but not HSV-1, Siglecg/
macrophages produced more IFN-b, TNF-a, and IL-6 protein
and expressed higher IFN-b and IFN-a4 mRNA than Siglecg+/+
macrophages (Figures 3A, 3B and S3A). The same phenom-
enon was also observed in bone-marrow-derived dendritic
cells (BMDCs) (Figures S3B and S3C). As to the response to
TLR ligands, Siglecg/ macrophages produced IFN-b more
obviously than Siglecg+/+ macrophages in response to intracel-
lular transfection of poly(I:C) (Figure S3D). By contrast, no dif-
ference in IFN-b secretion was observed between Siglecg/
and Siglecg+/+ macrophages stimulated with LPS, R837,470 Cell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc.poly(I:C), and LM or transfected with
poly(dA:dT) or poly(dG:dC) (Figure S3E).
We further confirmed that siRNA knock-
down of Siglecg significantly increased
the production of IFN-b and mRNA ex-
pression of IFN-b and IFN-a4 in macro-
phages infected with VSV or SeV (Fig-
ures 3C–3E). Furthermore, RAW264.7
macrophages with Flag-tagged Siglec-G
stably overexpressed produced less
IFN-b and expressed lower IFN-b and
IFN-a4 mRNA in response to infec-
tion with VSV or SeV, but not HSV-1
(Figures 3F–3H). Correspondingly, virus
replication was more significantly in-
hibited in Siglecg/ macrophages in-
fected with VSV (Figure 3I), and
enhanced viral replication was observed
in Siglec-G-overexpressing RAW264.7macrophages infected with VSV (Figure 3J). These data sug-
gest that Siglec-G selectively suppresses production of type I
interferon and inhibits antiviral innate response against RNA
viral infection.
Siglecg Deficiency Enhances IRF3 Activation by RNA
Viral Infection through the RIG-I Pathway
We further investigated the effect of Siglecg deficiency on
RNA virus activated downstream signal pathways in macro-
phages. We found that phosphorylation of IKK and IRF3
was markedly enhanced in Siglecg/ macrophages compared
with Siglecg+/+ macrophages after VSV infection. By con-
trast, we did not observe an appreciable difference in p65,
p38, ERK, and JNK phosphorylation between Siglecg/ and
Figure 3. Siglec-G Selectively Inhibits RNA-
Virus-Induced Production of Type I Inter-
feron in Macrophages
(A) ELISA of IFN-b in supernatants of Siglecg+/+
and Siglecg–/– peritoneal macrophages infected
for 24 hr with VSV, SeV, or HSV-1.
(B) Q-PCR analysis of IFN-b and IFN-a4
mRNA expression in Siglecg+/+ and Siglecg–/–
macrophages infected for 8 hr with VSV, SeV,
or HSV-1.
(C) Q-PCR analysis of Siglec-G mRNA expression
in macrophages 48 hr after transfection with
Siglecg siRNA.
(D) ELISA of IFN-b in supernatants of macro-
phages transfected as in (C) and 48 hr later in-
fected for 24 hr with VSV, SeV, or HSV-1.
(E) Q-PCR analysis of IFN-b and IFN-a4 mRNA
expression in macrophages transfected as in (C)
and 48 hr later infected for 8 hr with VSV, SeV, or
HSV-1.
(F) Immunoblot analysis of Siglec-G expression
in Siglec-G-overexpressing RAW264.7 macro-
phages with a-Flag.
(G) ELISA of IFN-b in supernatants of Siglec-G-
overexpressing RAW264.7 macrophages infected
for 24 hr with VSV, SeV, or HSV-1.
(H) Q-PCR analysis of IFN-b and IFN-a4 mRNA
expression in Siglec-G-overexpressing RAW264.7
macrophages infected for indicated time with
VSV, SeV, or HSV-1.
(I) Determination of VSV titers in supernatants of
Siglecg +/+ and Siglecg–/– peritoneal macrophages
changed culture medium for indicated hours after
VSV infection for 8 hr by TCID50 assay.
(J) Determination of VSV titers in supernatants
of Siglec-G-overexpressing RAW264.7 macro-
phages infected for indicated hours with VSV by
TCID50 assay.
Data are means ± SEM. *p < 0.05; **p < 0.01. See
also Figure S3.Siglecg+/+ macrophages (Figures 4A and 4B). Deficiency in
Siglecg resulted in more VSV-induced nuclear translocation of
IRF3 (Figure 4C). Moreover, deficiency in Siglecg maintained
higher expression of RIG-I at basal level and increased RIG-I
protein expression in macrophages after infection with VSV
(Figure 4D) or SeV (Figure S4A). However, little or no differ-
ence in expression of MAVS was detected (Figures 4D and
S4A). We also observed that expression of Siglec-G pro-
tein was upregulated in Siglecg+/+ macrophages with VSV
infection for 16 hr, and RIG-I protein level was lower at
the time point (Figure 4E). Phosphorylation of IRF3 was de-
creased with lower expression of RIG-I after VSV or SeV
infection in Siglec-G-overexpressing RAW264.7 macrophages
compared to control cells (Figures 4F and S4B). The cyclohex-Cell 152, 467–478imide chase assay of macrophages
showed that Siglecg deficiency in-
creased the half-life of endogenous
RIG-I protein during VSV infection (Fig-
ure 4G). Collectively, these results sug-
gest that Siglec-G negatively regulatesRNA-virus-induced IRF3 activation by reducing RIG-I protein
expression accordingly.
Siglec-G Promotes c-Cbl-Mediated Ubiquitination and
Degradation of RIG-I
To investigate the underlying mechanisms involved in the
negative regulation of RIG-I pathway by Siglec-G, we immuno-
precipitated Siglec-G from lysates of VSV-infected RAW264.7
macrophages stably overexpressing Flag-Siglec-G with an anti-
body against the Flag epitope tag and then used mass spec-
trometry to identify Siglec-G-associated proteins. Among the
Siglec-G-interacting proteins detected in the immunoprecipi-
tates, we focused on E3 ligases in the data set for their possi-
bility in regulating RIG-I turnover. A total of three E3 ligases, January 31, 2013 ª2013 Elsevier Inc. 471
Figure 4. SiglecgDeficiency Enhances IRF3
Activation in RNA-Virus-Infected Macro-
phages with Higher Expression of RIG-I
(A and B) Immunoblot analysis of phosphorylated
(p-) or total proteins in lysates of Siglecg+/+ or Si-
glecg–/– peritoneal macrophages infected for
indicated hours with VSV.
(C) Immunoblot analysis of IRF3 among nuclear
proteins from Siglecg+/+ or Siglecg–/– macro-
phages infected with VSV; lamin A/C serves as
a loading control.
(D) Immunoblot analysis of RIG-I and MAVS in
lysates of Siglecg+/+ or Siglecg–/– macrophages
infected with VSV.
(E) Immunoblot analysis of RIG-I and Siglec-G in
lysates of Siglecg+/+ or Siglecg–/– macrophages
infected with VSV.
(F) Immunoblot analysis of RIG-I and p-IRF3 in
lysates of Siglec-G-overexpressing RAW264.7
macrophages infected with VSV.
(G) Immunoblot analysis of RIG-I in lysates of Si-
glecg+/+ or Siglecg–/– macrophages treated with
CHX (100mg/ml) for indicated hours after infection
with VSV for 2 hr. Quantification of relative RIG-I
levels is shown in the bottom panel. Numbers
below lanes (top) indicate densitometry of the
protein presented relative to b-actin or GAPDH
expression in that same lane (below).
See also Figure S4.were identified as putative Siglec-G-binding proteins, and
we chose to study c-Cbl first, given that it has the highest
Mascot scores and the highest number of matched peptides
(Figure S5A). We observed that the level of ubiquitination con-
jugated to RIG-I was low in the absence of ectopic c-Cbl ex-
pression (Figure 5A), and the levels of RIG-I were reduced
as increasing amounts of c-Cbl were expressed. When cells
were treated with the proteasome inhibitor MG132, the deg-
radation of RIG-I was suppressed (Figure 5B). Under these
conditions, RIG-I expression was further reduced in the
presence of Siglec-G (Figure 5C). Knocking down c-Cbl with
specific siRNA in macrophages increased the half-life of endog-
enous RIG-I protein during VSV infection (Figure S5B). These
results suggest that Siglec-G functionally promotes c-Cbl
to regulate the levels of RIG-I protein through proteasomal
degradation.
Considering that the activated Siglec-G has ITIMs capable
of recruiting the tyrosine phosphatase SHP2, we investigated472 Cell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc.whether the tyrosine residues of
Siglec-G were phosphorylated and
whether Siglec-G promotes c-Cbl to
regulate the RIG-I pathway via SHP2
upon RNA virus infection. At 1 hr after
Siglec-G-overexpressing RAW264.7
macrophages were infected with VSV,
tyrosine phosphorylation of Siglec-G
increased markedly (Figure 5D). At 8 hr
after VSV infection, there was much
less phosphorylation of c-Cbl and SHP2
in Siglecg/ macrophages than in
Siglecg+/+ macrophages (Figure 5E). The IFN-b mRNA expres-
sion increased in VSV-infected macrophages treated with
specific siRNA for c-Cbl or SHP2 (Figures 5F and 5G). Similar ob-
servations were made in Siglec-G-overexpressing RAW264.7
macrophages (Figures S5C and S5D). On the contrary, the
IFN-b mRNA expression was attenuated in c-Cbl-overexpress-
ing RAW264.7 macrophages infected with VSV (Figure S5E).
We further found that knocking down c-Cbl with siRNA could up-
regulate IFN-b mRNA expression in shp2/ macrophages with
VSV infection. Interfering Siglec-G expression in shp2/macro-
phages with VSV infection did not affect IFN-b production (Fig-
ure 5H), suggesting that SHP2 might function upstream of
c-Cbl in this pathway. CD24 and some sialic acids are known
as ligands for Siglec-G (Chen et al., 2009). Using CD24/
mice, we found that CD24 deficiency did not affect VSV-induced
Siglecg expression and IFN-b production in macrophages
(Figures S5F–S5H). And knocking down Siglec-G with siRNA
still could increase the production of IFN-b in CD24-deficient
Figure 5. Siglec-G Promotes c-Cbl-Medi-
ated Degradation of RIG-I via SHP2
(A) c-Cbl is an E3 ligase for ubiquitin to RIG-I.
Plasmids encoding Flag-RIG-I and HA-ubiquitin
were cotransfected into HEK293T cells with or
without a plasmid encoding V5-c-Cbl. The RIG-I
ubiquitination was monitored by immunoprecipi-
tation. All cells were treated with MG132 (10 mM).
(B) c-Cbl mediates RIG-I degradation in a protea-
some-dependent manner. The HEK293T cells
were transfected with plasmids encoding Flag-
RIG-I, HA-ubiquitin, and varying doses of a
plasmid encoding V5-c-Cbl (0.5, 1.0, and 1.5 mg).
Half of each cell aliquot was treated with MG132
(10 mM). The level of RIG-I protein was examined in
cells harvested 24 hr after transfection.
(C) Siglec-G promotes c-Cbl-mediated degrada-
tion of RIG-I in a dose-dependent manner. The
HEK293T cells were transfected with plasmids
encoding Flag-RIG-I, HA-ubiquitin, V5-c-Cbl, and
varying doses of a plasmid encoding Myc-Siglec-
G (0.5 and 1 mg). The level of RIG-I protein was
examined in cells harvested 24 hr later.
(D) VSV infection induces tyrosine phosphoryla-
tion of Siglec-G. Flag-Siglec-G-overexpressing
RAW264.7 macrophages were infected with
VSV for the indicated hours. Immunoblot analysis
of phosphorylated tyrosine (p-Tyr) protein in
cell lysates immunoprecipitated with antibody
to Flag tag.
(E) Siglec-G promotes phosphorylation of c-Cbl
and SHP2. Immunoblot analysis of phosphory-
lated (p-) c-Cbl and p-SHP2 protein in lysates of
Siglecg–/– or Siglecg+/+ macrophages infected
with VSV.
(F and G) Siglec-G inhibits IFN-b production
through c-Cbl or SHP2. Q-PCR analysis of IFN-b
mRNA expression in macrophages transfected
with c-Cbl siRNA (F) or SHP2 siRNA (G) and 48 hr
later infected for indicated hours with VSV.
(H) SHP2 functions upstream of c-Cbl in Siglec-G
inhibition of IFN-b production. Q-PCR analysis of
IFN-b mRNA expression in shp2/macrophages
transfected with Siglec-G siRNA or c-Cbl siRNA
and 48 hr later infected for indicated hours
with VSV.
Data are means ± SEM. *p < 0.05. See also
Figure S5.macrophages infected with VSV (Figure S5I). Sialidase treatment
did not affect the phenotype of the increased IFN-b production in
Siglecg/macrophages upon VSV infection (Figure S5J). These
findings demonstrate that Siglec-G promotes c-Cbl-mediated
degradation of RIG-I via SHP2 to regulate RNA-virus-induced
type I IFN production.
Siglec-G Associates with SHP2, c-Cbl, and RIG-I
Coimmunoprecipitation experiments revealed that Siglec-G in-
teracts with c-Cbl/SHP2/RIG-I, and RIG-I interacts with c-Cbl/
SHP2/Siglec-G in various tagged plasmids coexpressed in
HEK293T cells (Figure 6A). Interaction between Flag-tagged
Siglec-G and endogenous RIG-I/c-Cbl/SHP2 was readily de-tected in Siglec-G-overexpressing RAW264.7 macrophages in-
fected with VSV (Figure 6B). Furthermore, the endogenous
Siglec-G/RIG-I/c-Cbl/SHP2 complex was also detected in
VSV-infected peritoneal macrophages from Siglecg+/+ mice.
However, the association was almost undetected in VSV-in-
fected peritoneal macrophages from Siglecg–/– mice (Figure 6C).
Confocal microscopy also revealed that intracellular RIG-I local-
ized together with c-Cbl and Siglec-G in cytoplasm of HEK293T
cells 6 hr after infection with SeV (Figure 6D).
Siglec-G contains four ITIM motifs in the intercellular domain.
Binding analysis revealed that the Siglec-G (4YF) mutant inter-
acted to RIG-I much more weakly than full-length Siglec-G,
whereas the cytoplasmic domain-deleted Siglec-G mutant didCell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc. 473
Figure 6. Siglec-G Interacts with SHP2,
c-Cbl, and RIG-I
(A) Protein complex of Siglec-G, SHP2, c-Cbl, and
RIG-I in overexpressing system. The HEK293T
cells were transfected for 24 hr with plasmids
encoding HA-RIG-I, Flag-SHP2, Flag-c-Cbl, and
Myc-Siglec-G. Immunoblot analysis of Myc-
Siglec-G, HA-RIG-I, Flag-SHP2, or Flag-c-Cbl
immunoprecipitated with antibodies to myc or
HA tags.
(B) Protein complex of Flag-Siglec-G, SHP2,
c-Cbl, and RIG-I in macrophages. Siglec-G-
overexpressing RAW264.7 macrophages were
infected with VSV for indicated hours. Immunoblot
analysis of endogenous RIG-I, SHP2, or c-Cbl
immunoprecipitated with antibody to SHP2 or
Flag tag.
(C) Interaction of Siglec-G, c-Cbl, and RIG-I with
SHP2 in peritoneal macrophages. Siglecg–/– or
Siglecg+/+ macrophages were infected with VSV
for indicated hours. Immunoblot analysis of
endogenous Siglec-G, RIG-I, c-Cbl, or SHP2
immunoprecipitated with antibody to SHP2. IgG
was as control.
(D) Confocal microscopy of HEK293 infected for
6 hr with SeV. HEK293T cells were transfected
with Flag-RIG-I, Myc-c-Cbl, Flag-Siglec-G, or
Myc-RIG-I for 24 hr and then infectedwith SeV and
labeled with antibodies to the appropriate mole-
cules.
(E) Intracellular domain of Siglec-G associates with
RIG-I. Schematic structure of Siglec-G and the
derivatives used were shown (top). WCLs of
HEK293T cells transfected with Myc-Siglec-G
(WT), Myc-Siglec-G (Del), Myc-Siglec-G (4YF), and
Flag-RIG-I were used for immunoprecipitation and
immunoblotting, as indicated.
(F) Siglec-G associates with the Helix/CTD of
RIG-I. Schematic structure of RIG-I and the
derivatives used were shown (top). WCLs of
HEK293T cells transfected with Myc-RIG-I (WT),
Myc-RIG-I (2CARD), Myc-RIG-I(Heli), Myc-RIG-
I(CTD), or with Myc-RIG-I(DCARD) and HA-
Siglec-G were used for immunoprecipitation and
immunoblotting, as indicated.not interact with RIG-I (Figure 6E). Coexpressing plasmids in
HEK293T revealed that SHP2 promoted Siglec-G interaction
with RIG-I (Figure S6A), indicating that ITIM motifs of Siglec-G
are important for Siglec-G to associate with RIG-I through re-
cruiting SHP2. To determinewhich domain of RIG-I was required
for the interaction of RIG-I with Siglec-G or c-Cbl, we con-
structed mutants of RIG-I with the deletion of various domains
and found that Heli or/and CTD domain of RIG-I interacted
with Siglec-G (Figure 6F) and CTD domain of RIG-I associated
with c-Cbl (Figure S6B).
Lys813 Is a Critical Site in c-Cbl-Mediated K48-Linked
Ubiquitination of RIG-I
Based on c-Cbl-mediated ubiquitination and degradation of
RIG-I, we analyzed K48-linked ubiquitin to RIG-I, and found
that Siglec-G promoted c-Cbl-mediated K48-linked ubiquitina-
tion and degradation of RIG-I in a dose-dependent manner
(Figures 7A, 7B, S7A, S7B, S7D, and S7E). c-Cbl did not474 Cell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc.substantially affect K63-linked ubiquitination and degradation
of RIG-I (Figures S7E and S7F).
We further analyzed the most conserved lysine residues
of RIG-I among different species and constructed those plas-
mids in which lysine residues were replaced with arginine
(K/R) individually (data not shown). The K813R mutation
caused near-complete loss of K48 ubiquitination and deg-
radation of RIG-I (Figures 7C, 7D, S7C, and S7G). Transfection
of RIG-I-K813R induced IFN-b promoter activation more
markedly in HEK293T cells, consistent with their lack of ubiq-
uitination and degradation of RIG-I (Figure 7E). Furthermore,
VSV infection induced much more IFN-b mRNA expression in
RIG-I-K813R-overexpressing RAW264.7 macrophages than in
wild-type RIG-I-overexpressing RAW264.7 macrophages (Fig-
ure S7H). In RIG-I-deficient peritoneal macrophages, transfec-
tion of the RIG-I-K813R mutant restored VSV-induced IFN-b
expression significantly more than transfection of wild-type
RIG-I (Figure 7F). These results suggest that Lys813 of RIG-I
Figure 7. Lys813 of RIG-I Is a Critical Site in
c-Cbl-Mediated K48-Linked Ubiquitination
and Degradation of RIG-I
(A) Siglec-G promotes c-Cbl-mediated K48-linked
ubiquitination of RIG-I. The HEK293T cells were
transfected with plasmids encoding Flag-RIG-I,
HA-ubiquitin, V5-c-Cbl, and varying doses of
a plasmid encoding Myc-Siglec-G (0, 0.5, and
1 mg). Half of each cell aliquot was treated with
MG132 (10 mM). Cells were harvested 24 hr after
transfection for immunoblot analysis of K48-Ub
immunoprecipitated with antibody to Flag tag.
(B) c-Cbl mediates K48-linked ubiquitination of
RIG-I in a dose-dependent way. The HEK293T
cells were transfected with plasmids encoding
Myc-RIG-I, HA-ubiquitin, Flag-Siglec-G, and
varying doses of a plasmid encoding V5-c-Cbl
(0, 0.5, and 1 mg). Half of each cell aliquot was
treated with MG132 (10 mM). Cells were harvested
24 hr after transfection for immunoblot analysis
of K48-Ub immunoprecipitated with antibody to
myc tag.
(C) K813 of RIG-I is the major site of c-Cbl-medi-
ated K48-linked ubiquitination. WCLs of HEK293T
cells transfectedwith HA ubiquitin, V5-c-Cbl, Myc-
RIG-I (WT), or K/R mutants were used for
immunoprecipitation and immunoblot analysis of
K48-Ub. Half of each cell aliquot was treated with
MG132 (10 mM).
(D) K813 is critical site in c-Cbl-mediated degra-
dation of RIG-I. WCLs of HEK293T cells trans-
fected with V5-c-Cbl, HA-ubiquitin, Flag-Siglec-G,
Myc-RIG-I WT, or K813R mutants were used for
immunoblot analysis of RIG-I with antibody to
myc tag.
(E) IFN-b promoter activity in RIG-I-WT or RIG-I-
K813R-transfected HEK293T cells detected by
luciferase reporter assay. Luciferase activity was
analyzed as fold induction. Data are means ±
SEM. **p < 0.01.
(F) Q-PCR analysis of IFN-b mRNA expression in
Rigi/ macrophages transfected with RIG-I-WT
or RIG-I-K813R plasmid and 24 hr later infected for
8 hr with VSV. Data are means ± SEM. *p < 0.05.
(G) Model of the RNA-virus-activated Siglec-G-SHP2-c-Cbl-mediated RIG-I degradation. Upon RNA virus infection, Siglec-G is activated, and then its
phosphorylated ITIMs recruit tyrosine phosphatase SHP2. Siglec-G promotes phosphorylation of SHP2 and c-Cbl. RIG-I is also recruited and associated with
Siglec-G-SHP2-c-Cbl, leading to K48-linked ubiquitination and proteasomal degradation of RIG-I by E3 ligase c-Cbl. Lys813 of RIG-I is a critical site for c-Cbl-
mediated RIG-I degradation. On the other hand, RNA virus infection triggers RIG-I downstream signal activation through RIG-I-MAVS interaction, and the
activated NF-kB upregulates Siglec-G mRNA expression, which inhibits RIG-I-triggered type I interferon production in the innate immune response, forming
a negative feedback loop.
See also Figure S7.is an important site for K48 ubiquitination and degradation of
RIG-I.
DISCUSSION
RLR signaling is regulated at multiple steps in the signaling
cascade. The helicase and repressor domain (RD) of RIG-I
bind RNA ligands, leading to a conformational change that
releases CARDs from RD repression, activating signaling (Jiang
et al., 2011; Kowalinski et al., 2011). During virus infection, ATP
and dsRNA binding induces a major rearrangement, creating
a closed conformation in which the helicase and CTD binddsRNA. This co-operative tight binding liberates the CARDs for
downstream signaling. The CARDs interact with the adaptor
protein MAVS/IPS-1/VISA/Cardif to form a MAVS signalosome
that drives type I IFN production (Kowalinski et al., 2011; Seth
et al., 2005; Hou et al., 2011; O’Neill and Bowie, 2011). Negative
regulators of RIG-I signaling pathway include deubiquitinases
such as CYLD, which interact with the CARDs of RIG-I to remove
K63-linked polyubiquitin chains and inhibit downstream sig-
naling (Friedman et al., 2008). However, only RNF125 E3 ligase
has thus far been reported to mediate polyubiquitination and
degradation of RIG-I (Arimoto et al., 2007). Further investigation
will be required to identify additional ubiquitination sites andCell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc. 475
other ubiquitin ligases or proteins that can regulate RIG-I
signaling. Here, we have shown that Siglec-G, upregulated by
RNA virus, promotes c-Cbl-mediated K48-linked ubiquitination
on Lys813 of RIG-I and subsequent degradation of RIG-I. To
our knowledge, this is the first report of K48-linked ubiquitination
of RIG-I and also the critical site (Lys813) of RIG-I for ubiquitina-
tion and degradation. Our results, showing that overexpressed
RIG-I-K813R is quite stable in HEK293 cells in which RNF125
and other E3 ligases also express, indicate that Lys813 may
also be a ubiquitination site for RNF125 or the key site for K48-
linked ubiquitination of RIG-I by all others E3 ligases. Thus, our
study provides a new manner for negative regulation of RIG-I
at the posttranslational level and identifies a previously unknown
function of E3 ligase c-Cbl that could mediate proteasomal
degradation of RIG-I.
Cbls (c-Cbl, Cbl-b, andCbl-c) are single-subunit RINGE3s that
negatively regulate a host of proteins by promoting their ubiquiti-
nationandsubsequentdegradationby theproteasomeor through
endocytosis (Joazeiro et al., 1999; Schmidt and Dikic, 2005). The
ligase activity of human c-Cbl is regulated by Try371 phosphory-
lation to break autoinhibition (Dou et al., 2012), but the phosphor-
ylated tyrosine site ofmurinec-Cbl for activation is not clear.Here,
we have shown that a higher Try731 phosphorylation level of
murine c-Cbl occurred in Siglecg+/+ macrophage compared to
Siglecg/macrophage upon VSV infection, which may promote
c-Cbl activation. Given reports that c-Cbl is associated with
SHP2 following stimulation by SDF-1 (Chernock et al., 2001)
and that the c-Cbl/SHP2 complex is involved in ubiquitination
and degradation of gp130 upon IL-6 stimulation (Tanaka et al.,
2008), we detected an interaction between RIG-I and c-Cbl via
SHP2. Our data showed that recruiting of SHP2 by Siglec-G is
involved in c-Cbl-mediated negative regulation of RIG-I signaling
for type I IFN production. Thus, the precise mechanism of c-Cbl
activation and relationship between c-Cbl and SHP2 need further
investigation. Our lab previously reported that SHP2 negatively
regulates MyD88 and TRIF-mediated gene expression in TLR
signaling, in part by interfering with TRAF6-mediated signaling
and through inhibition of TBK1-activated signal transduction (An
et al., 2006; Xu et al., 2012). By showing a critical role for SHP2
in RLR regulation, we extended the function of SHP2 into PRRs
known to be involved in regulating viral infection.
Siglec-G belongs to a superfamily of immunoglobulin-like lec-
tins defined by their ability to recognize sialic-acid-containing
structures, functioning as a negative regulator of BCR-mediated
signaling and an inhibitory receptor of B1 cells. Although CD24
and some sialic acids are known as ligands for Siglec-G (Chen
et al., 2009), we confirmed that negative function of Siglec-G in
VSV-induced IFN-b production is not dependent on its interac-
tion with CD24 molecule or other sialic acids presented on the
cell surface of macrophages. We speculated that sialic acids
of viral glycoproteins, but not sialic acids on the surface of
macrophages, might be recognized by Siglec-G and then trigger
the downstream signal. The tyrosines within the ITIM of Siglec-G
become phosphorylated by following ligation of the receptors
and recruit SHP1/2 to regulate cellular activity (Crocker et al.,
2007). However, the regulation of Siglec-G expression and its
roles in innate immunity are unclear. Consistent with the obser-
vation that Siglec-G deficiency did not affect the production of476 Cell 152, 467–478, January 31, 2013 ª2013 Elsevier Inc.inflammatory cytokines by DCs in response to LPS or poly(I:C)
(Chen et al., 2009), our finding that Siglec-G inhibits induction
of type I IFN production by RNA virus infection in macrophages
may provide new insight into the biological function of Siglec-G
in innate immunity.
TLRs are key sensors that trigger signaling cascades to
activate inflammatory programs via the NF-kB gene network.
Interestingly, NF-kB, activated by RIG-I but not TLRs, could
upregulate Siglec-G expression. We found that LPS stimulation
did not affect the significantly increased H3K4me3 and/or
decreased H3K27me3 levels in macrophages infected by VSV.
The data revealed a functional link between regulation of gene
expression and epigenetic control of NF-kB signaling in the regu-
lation of innate immunity. The phenomenon also opens a gate to
how a virus can escape immune attack and survive by upregulat-
ing Siglec-G through epigenetic modification.
Here, we have shown that Siglec-G is specifically upregulated
by RNA virus infection and regulates RIG-I signaling in macro-
phages through a negative feedbackmechanism. Consequently,
Siglec-G suppresses type I IFN production by promoting c-Cbl-
mediated K48-linked ubiquitination and proteasomal degrada-
tion of RIG-I. This process depends on phosphorylation of
SHP2 and c-Cbl, as illustrated in Figure 7G. This working model
explains why Siglecg-deficient mice show more resistance to
RNA virus infection. These findings provide insight into the
negative regulation of RIG-I-mediated antiviral innate immune
responses, a mechanistic explanation for the immunological
escape of RNA virus, and potential therapeutic targets for
virus-associated inflammatory diseases.
EXPERIMENTAL PROCEDURES
Plasmids, cells, pathogens, antibodies, ELISA kits, and other reagents used,
as well as detailed experimental procedures can be found in the Extended
Experimental Procedures.
Mice
Siglecg/ and CD24/mice on a C57BL/6J background were generated as
described previously (Ding et al., 2007; Nielsen et al., 1997). Rigi/ mice on
a 129/Sv/C57BL/6J background were kindly provided by Dr. Zhugang Wang
(Wang et al., 2007). Shp2fl mice were a kind gift from Dr. Gensheng Feng.
Mx-Cre mice and mice deficient in Irf3, Ifnb, and Ifnabr were from Jackson
Laboratories. C57BL/6J mice were purchased from Joint Ventures Sipper
BK Experimental Animals (Shanghai, China). Mice were kept and bred in path-
ogen-free conditions. All animal experiments were undertaken in accordance
with the National Institute of Health Guide for the Care and Use of Laboratory
Animals with approval of the Scientific Investigation Board of Second Military
Medical University, Shanghai.
Coimmunoprecipitation, Immunoblot Analysis, RT-PCR, RNAi,
Luciferase Reporter Assay, and VSV TCID50 Assay
These experiments were performed as described previously (Hou et al., 2009;
Yang et al., 2010; Liu et al., 2011).
Immunofluorescent Confocal Microscopy
The experiments were performed as described previously (Xu et al., 2012).
Imaging of the cells was carried out using Leica TCS SP2 confocal laser
microscopy under a 1003 oil objective.
Microarray Analysis
Total RNA was isolated using an RNA isolation kit (QIAGEN) and was
verified with RNA integrity number (RIN). Whole-genome-wide expression
analysis was performed with Affymetrix Mouse Genome 430 2.0 Arrays.
Differentially expressed genes were identified using Limma (Bioconductor
package) in R software. Detailed procedures are described in the Extended
Experimental Procedures.
Lung Histology
Lungs from control or virus-infected mice were dissected, fixed in 10%
phosphate-buffered formalin, embedded into paraffin, sectioned, stained
with hematoxylin and eosin solution, and examined by light microscopy for
histological changes. Immunohistochemical staining was performed using
standard procedures.
Isolation of Macrophages and BMDCs
Peritoneal macrophages were harvested from mice 4 days after thioglycol-
late (BD, Sparks, MD) injection. BMDCs from C57BL/6J mice were generated
as described previously (Liu et al., 2011). Cells were plated into 12-well
plates and cultured in the absence or presence of LPS (100 ng/ml), CpG
ODN(0.3 mM), R837(10 mg/ml), poly(I:C) (10 mg/ml), poly(dA:dT) (10 mg/ml),
poly(dG:dC) (10 mg/ml), LM DNA (10 mg/ml), LM (10 M.O.I.) or E. coli (6 3
104 CFU).
Virus Infection
Cells were infected with VSV (1 MOI), SeV (1 MOI), or HSV-1(10 MOI) for the
indicated hours. Cytokine productionwas analyzed 24 hr later. For in vivo cyto-
kine production studies, age- and sex-matched groups of littermate mice were
intraperitoneally infected with VSV (13 108 pfu per mouse), SeV (13 103 TCID
50/ml per mouse), or HSV-1 (1 3 108 pfu per mouse).
Statistical Analysis
Statistical significance between groups was determined by two-tailed
Student’s t test and two-way ANOVA test. Differences were considered to
be significant when p < 0.05. For mouse survival study, Kaplan-Meier survival
curves were generated and analyzed for statistical significance with GraphPad
Prism 4.0.ACCESSION NUMBERS
Array data are available at Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) under the accession number GSE39620.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures and two tables and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2013.01.011.
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